Skip to main content

CORRECTION article

Front. Neurol., 28 March 2023
Sec. Multiple Sclerosis and Neuroimmunology
Volume 14 - 2023 | https://doi.org/10.3389/fneur.2023.1187907

Corrigendum: Case report and literature analysis: Autoimmune cerebellar ataxia associated with homer-3 antibodies

This article is a correction to:

  1. Case report and literature analysis: Autoimmune cerebellar ataxia associated with homer-3 antibodies

    1. Read original article
\nQisi WuQisi Wu1Beibei GongBeibei Gong2Anan JiangAnan Jiang1Xinyue Qin Xinyue Qin1*
  • 1Department of Neurology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China
  • 2Department of Radiology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China

A corrigendum on
Case report and literature analysis: Autoimmune cerebellar ataxia associated with homer-3 antibodies

by Wu, Q., Gong, B., Jiang, A., and Qin, X. (2022). Front. Neurol. 13:951659. doi: 10.3389/fneur.2022.951659

In the published article, there was an error in the Funding statement. The grant number was incorrect. The correct Funding statement appears below.

Funding

This work was supported by the Natural Science Foundation of Chongqing (grant no. cstc2020jcyj-msxmX0765).

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Publisher's note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Keywords: autoimmune cerebellar ataxia, Homer-3 antibody, brain MRI enhanced abnormalities, relapse, rituximab

Citation: Wu Q, Gong B, Jiang A and Qin X (2023) Corrigendum: Case report and literature analysis: Autoimmune cerebellar ataxia associated with homer-3 antibodies. Front. Neurol. 14:1187907. doi: 10.3389/fneur.2023.1187907

Received: 16 March 2023; Accepted: 17 March 2023;
Published: 28 March 2023.

Approved by:

Frontiers Editorial Office, Frontiers Media SA, Switzerland

Copyright © 2023 Wu, Gong, Jiang and Qin. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Xinyue Qin, qinxinyuecq2008@sina.com

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.